Abstract:Preovulatory follicles of immature mice primed with eCG ovulate 12∼16 hours following hCG treatment. When cumulus-oocyte-complexes (COC) are collected from the oviduct 24 hours after hCG, the hyaluronan rich matrix of the expanded COCs is disorganized and cumulus cells exhibit elevated levels of immuno-reactive activated caspase 3, a marker of apoptosis. In contrast, in COCs collected immediately following ovulation (12h post-hCG) the expanded matrix was intact and no signs of apoptosis were evident in cumulus cells. When COCs were cultured with FSH or the EGF-like factor amphiregulin (AREG) cumulus expansion is stimulated in a manner similar to that in vivo. Likewise, by 24 hours the matrix was disrupted and cumulus cells showed high levels of activated caspase 3. Since granulosa cells cultured under identical conditions remain viable and differentiate, these data indicate that cumulus cell apoptosis may be innate to COCs. When gene expression profiles from COCs collected at 0h, 8h and 16h post-hCG treatment were compared, BMP15 was one of the genes showing a significant (80%) decrease at 8h and 16h compared to 0h. The decrease in BMP15 mRNA was confirmed by real-time RT-PCR analyses of RNA prepared from COCs collected at 0h, 2h, 4h, 8h, 12h and 16h post hCG. BMP15 expression peaked at 2h but then dropped to 50% at 4h and to 15% at 12h and 16h. To determine if BMP15 could prevent cumulus cell apoptosis, different concentrations of purified BMP15 protein were added to COCs cultured for 12, 16 and 24h. The integrity of the hyaluronan matrix and the levels of activated caspase 3 were compared using immuno-fluorescence microscopy. BMP15 alone had little effect on COCs. However, when BMP15 was combined with FSH or AREG there was a significant 4-hour delay of apoptosis. The effect of BMP15 was dose-dependent with the maximum response achieved at the highest dose of 100ng/ml. Western blot analyses showed that activated caspase 3 levels were reduced in the FSH/BMP15 treated COCs. Thus, these data indicate that BMP15 can synergize with FSH and AREG to delay, but not prevent apoptosis in cumulus cells in expanded COC. Further investigation of the mechanisms that control cumulus cell apoptosis should help to reveal factors that regulate the fate of COCs and may potentially identify markers that can be used to judge the quality of oocytes in in vitro fertilization. (platform)

The Associations Between Expression of GDF-9 and BMP-15 in Oocytes and CGC and Different Ovarian Responses

High Bone Morphogenetic Protein-15 Level in Follicular Fluid is Associated with High Quality Oocyte and Subsequent Embryonic Development

GDF-9 and BMP-15 Expression in Oocytes and Cumulus Granulosa Cells of PCOS Patients

[Women with Poor Response to Ovarian Stimulation Have Increased Follicular Bone Morphogenetic Protein-15 Levels].

ADAMTS1 and HSPG2 mRNA levels in cumulus cells are related to human oocyte quality and controlled ovarian hyperstimulation outcomes

High expression of CFTR in cumulus cells from mature oocytes is associated with high-quality of oocyte and subsequent embryonic development

Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity

Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome.

Influence of Bone Morphogenetic Protein(BMP)-15 on the IVF Outcomes of Endometriosis——A Clinical Trail and Experimental Research

Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders

Application of specific ELISAs for BMP15 and GDF9 to cumulus cell extracts from infertile women

Expression of TGFβ Superfamily Components and Other Markers of Oocyte Quality in Oocytes Selected by Brilliant Cresyl Blue Staining: Relevance to Early Embryonic Development.

Follicular localization of GDF 8 and its receptors in normal and PCOS ovaries.

G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve.

Poor Ovarian Response To Gonadotropin Stimulation Is Associated With Low Expression Of Follicle-Stimulating Hormone Receptor In Granulosa Cells

Stage-specific Expression of Bone Morphogenetic Protein Type I and Type II Receptor Genes: Effects of Follicle-Stimulating Hormone on Ovine Antral Follicles

The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient

The Roles of GDF-9, BMP-15, BMP-4 and EMMPRIN in Folliculogenesis and In Vitro Fertilization

The Effects of Bmp15 on Cumulus Cell Apoptosis.

Relationship between expression of follicle-stimulating hormone receptor in granulose cells and ovarian response in in vitro fertilization cycles

Expression of Gonadotrophin Receptor and Influencing Factors among Different Ovarian Reserve Patients